Glomerular inflammation in renal allografts biopsies after the first year: Cell types and relationship with antibody-mediated rejection and graft outcome

Transplantation

Volumn 90, Issue 12, 2010, Pages 1478-1485

  Papadimitriou, John C ^a   Drachenberg, Cinthia B ^a   Munivenkatappa, Raghava ^a   Ramos, Emilio ^a   Nogueira, Joseph ^a   Sailey, Charles ^a   Klassen, David K ^a   Haririan, Abdolreza ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CD68; Diabetes mellitus; Glomerulitis; Glomerulonephritis; Graft failure; Hepatitis C; Ischemia; Macrophages; Thrombotic microangiopathy; Transplant glomerulopathy

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; CHLORDANE; COMPLEMENT COMPONENT C4D;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD VESSEL INJURY; CELL TYPE; FEMALE; GLOMERULITIS; GLOMERULOPATHY; GLOMERULUS; GRAFT FAILURE; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; CAPILLARIES; COMPLEMENT C4B; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION; ISOANTIBODIES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MICROCIRCULATION; PEPTIDE FRAGMENTS; RISK ASSESSMENT; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 78650844915     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ff87f5     Document Type: Article

References (48)

1. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
2. Sis B, Einecke G, Chang J, et al., Cluster analysis of lesions in nonselected kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant 2010; 10: 421.
3. Drachenberg CB, Steinberger E, Hoehn-Saric E, et al. Specificity of intertubular capillary changes: Comparative ultrastructural studies in renal allografts and native kidneys. Ultrastruct Pathol 1997; 21: 227.
4. Hidalgo LG, Campbell PM, Sis B, et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
5. Habib R, Broyer M. Clinical significance of allograft glomerulopathy. Kidney Int Suppl 1993; 43: S95.
6. Habib R, Zurowska A, Hinglais N, et al. A specific glomerular lesion of the graft: Allograft glomerulopathy. Kidney Int Suppl 1993; 42: S104.
7. Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: Evolution of morphologically distinct changes. Kidney Int 1985; 27: 799.
8. Olsen S. Pathology of the renal allograft rejection. In: Churg J, Spargo BH, Mostofi JK, eds. Kidney disease: Present status. Baltimore, Williams and Wilkins 1979, p 327.
9. Richardson WP, Colvin RB, Cheeseman SH, et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981; 305: 57.
10. Olsen S, Spencer E, Cockfield S, et al. Endocapillary glomerulitis in the renal allograft. Transplantation 1995; 59: 1421.
11. Axelsen RA, Seymour AE, Mathew TH, et al. Glomerular transplant rejection: A distinctive pattern of early graft damage. Clin Nephrol 1985; 23: 1.
12. Messias NC, Eustace JA, Zachary AA, et al. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001; 72: 655.
13. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002; 11: 609.
14. Trpkov K, Campbell P, Pazderka F, et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody: Analysis using the Banff grading schema. Transplantation 1996; 61: 1586.
15. Fahim T, Böhmig GA, Exner M, et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7: 385.
16. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63: 1888.
17. Petersen VP, Olsen TS, Kissmeyer-Nielsen F, et al. Late failure or human renal transplants. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years. Medicine (Baltimore) 1975; 54: 45-71.
18. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
19. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
20. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
21. Amico P, Hönger G, Mayr M, et al. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87: 1681.
22. Banfi G, Villa M, Cresseri D, et al. The clinical impact of chronic transplant glomerulopathy in cyclosporine era. Transplantation 2005; 80: 1392.
23. Colvin RB. Pathology of chronic humoral rejection. Contrib Nephrol 2009; 162: 75.
24. Gloor J, Cosio F, Lager DJ, et al. The spectrum of antibody-mediated renal allograft injury: Implications for treatment. Am J Transplant 2008; 8: 1367.
25. Haririan A, Kiangkitiwan B, Kukuruga D, et al. The impact of C4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy.AmJ Transplant 2009; 9: 2758.
26. Nankivell BJ, Borrows RJ, Fung CL, et al. Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation 2004; 78: 461.
27. Smith RN, Kawai T, Boskovic S, et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 2008; 8: 1662.
28. Wavamunno MD, O'Connell PJ, Vitalone M, et al. Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007; 7: 2757.
29. Regele H. [The role of endothelial cells in allograft rejection]. Pathologe 2008; 29(suppl 2): 141.
30. Akalin E, Dinavahi R, Dikman S, et al. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007; 2: 1261.
31. Cosio FG, Lager DJ, Lorenz EC, et al. Significance and implications of capillaritis during acute rejection of kidney allografts. Transplantation 2010; 89: 1088.
32. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42.
33. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
34. Loupy A, Hill GS, Nochy D, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2010; 10: 952; author reply 953.
35. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
36. Magil AB. Infiltrating cell types in transplant glomerulitis: Relationship to peritubular capillary C4d deposition. Am J Kidney Dis 2005; 45: 1084.
37. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68: 1866.
38. Segerer S, Heller F, Lindenmeyer MT, et al. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 2008; 74: 37.
39. Wilson HM, Walbaum D, Rees AJ. Macrophages and the kidney. Curr Opin Nephrol Hypertens 2004; 13: 285.
40. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009; 119: 1286.
41. Panzer U, Kurts C. T cell cross-talk with kidney dendritic cells in glomerulonephritis. J Mol Med 2010; 88: 19.
42. Lefaucheur C, Nochy D, Hill GS, et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7: 832.
43. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712.
44. Abbas, A.a.L.A. Cellular and molecular immunology [ed. 5]. Philadelphia, Elsevier Saunders 2005, 313.
45. Nasr SH, Markowitz GS, Valeri AM, et al. Thin basement membrane nephropathy cannot be diagnosed reliably in deparaffinized, formalinfixed tissue. Nephrol Dial Transplant 2007; 22: 1228.
46. Gough J, Yilmaz A, Miskulin D, et al. Peritubular capillary basement membrane reduplication in allografts and native kidney disease: A clinicopathologic study of 278 consecutive renal specimens. Transplantation 2001; 71: 1390.
47. Iványi B, Fahmy H, Brown H, et al. Peritubular capillaries in chronic renal allograft rejection: A quantitative ultrastructural study. Hum Pathol 2000; 31: 1129.
48. Ivanyi B, Kemeny E, Szederkenyi E, et al. The value of electron microscopy in the diagnosis of chronic renal allograft rejection. Mod Pathol; 2001; 14: 1200.